Yoshiyuki Miyazawa

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 8

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Akira Ohtsu, Seiji Arai, Yuji Fujizuka, Yoshiyuki Miyazawa, Masashi Nomura, Yoshitaka Sekine, Hidekazu Koike, Hiroshi Matsui, Yasuhiro Shibata, Kazuto Ito, Kazuhiro Suzuki
Predictive models of long-term survival outcomes following radical cystectomy. Cancer medicine (2023)
Yoshiyuki Miyazawa, Keisuke Hori, Yusuke Tsuji, Yoshitaka Sekine, Seiji Arai, Yuji Fujizuka, Masashi Nomura, Hidekazu Koike, Hiroshi Matsui, Kazuhiro Suzuki
The utility of the [-2]pro-prostate-specific antigen level as a prognostic marker in patients with castration-resistant prostate cancer treated with enzalutamide. International journal of urology : official journal of the Japanese Urological Association (2023)
Yoshiyuki Miyazawa, Toshiyuki Nakamura, Yutaka Takezawa, Nobuaki Shimizu, Yasushige Matsuo, Haruyuki Ogura, Tomoyuki Takei, Yoshitaka Sekine, Seiji Arai, Kazuhiro Suzuki
A prospective study of the relationship between CRPC patient's quality of life after enzalutamide and serum testosterone levels measured via LC-MS/MS. The Prostate (2023)
Yoshiyuki Miyazawa, Takanori Shimizu, Yoshitaka Sekine, Seiji Arai, Akira Ohtsu, Yuji Fujizuka, Masashi Nomura, Hidekazu Koike, Hiroshi Matsui, Kazuhiro Suzuki
Two cases of CRPC with BRCA mutation treated by olaparib after favorable response to cisplatin. IJU case reports 6 (1) (2022)
Yoshiyuki Miyazawa, Takanori Shimizu, Yoshitaka Sekine, Seiji Arai, Akira Ohtsu, Yuji Fujizuka, Masashi Nomura, Hidekazu Koike, Hiroshi Matsui, Kazuhiro Suzuki
Two cases of CRPC with BRCA mutation treated by olaparib after favorable response to cisplatin. IJU case reports 6 (1) (2022)
Hiroshi Nakayama, Yoshitaka Sekine, Daisuke Oka, Yoshiyuki Miyazawa, Seiji Arai, Hidekazu Koike, Hiroshi Matsui, Yasuhiro Shibata, Kazuhiro Suzuki
Combination therapy with novel androgen receptor antagonists and statin for castration-resistant prostate cancer. The Prostate (2021)
Narisa Dewi Maulany Darwis, Takahiro Oike, Hidemasa Kawamura, Masahiro Kawahara, Nobuteru Kubo, Hiro Sato, Yuhei Miyasaka, Hiroyuki Katoh, Hitoshi Ishikawa, Hiroshi Matsui, Yoshiyuki Miyazawa, Kazuto Ito, Kazuhiro Suzuki, Soehartati Gondhowiardjo, Takashi Nakano, Tatsuya Ohno
Kinetics of Prostate-Specific Antigen after Carbon Ion Radiotherapy for Prostate Cancer. Cancers 12 (3) (2020)
Yoshiyuki Miyazawa, Yoshitaka Sekine, Nobuaki Shimizu, Yutaka Takezawa, Toshiyuki Nakamura, Takeshi Miyao, Hiroshi Nakayama, Sota Kurihara, Takahiro Syuto, Masashi Nomura, Hidekazu Koike, Hiroshi Matsui, Yasuhiro Shibata, Kazuhiro Suzuki
An exploratory retrospective multicenter study of prognostic factors in mCRPC patients undergoing enzalutamide treatment: Focus on early PSA decline and kinetics at time of progression. The Prostate 79 (12) (2019)

Yoshiyuki Miyazawa.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yoshiyuki Miyazawa